A Cardiac Resynchronization Therapy (CRT) Related Image
(Not Necessarily related to the device)
Description:
CONTAK RENEWAL 3 CONTAK RENEWAL 3 HE by Boston Scientific Corp.
Boston Scientific Corp.'s CONTAK RENEWAL 3 CONTAK RENEWAL 3 HE is a cutting-edge medical device primarily designed for cardiac resynchronization therapy (CRT), aiming to improve quality of life and enliven the functionality of individuals afflicted with heart rhythm disorders.
The device's inherent prowess lies in its capability to provide dual-chamber pacing, designed to assist in regulating irregular or abnormal heart rhythms. Cognizant of the fact that every individual is unique, the CONTAK RENEWAL 3 CONTAK RENEWAL 3 HE also offers programmable settings that enable clinicians to tailor treatment strategies to each patient's specific needs.
One of the prime benefits offered by this device by Boston Scientific Corp. is its capacity to be integrated seamlessly into the patient's lifestyle. This is achieved by its long-lasting battery that redefines reliability, ensuring patients continue to receive their necessary treatment without frequent interruptions for device maintenance or replacement.
With the CONTAK RENEWAL 3 CONTAK RENEWAL 3 HE, patients and medical practitioners alike can trust in a device which is firmly grounded in the latest advancements in cardiac therapy and patient-focused design.
Primary Use:
Overview of CONTAK RENEWAL 3 CONTAK RENEWAL 3 HE
CONTAK RENEWAL 3 CONTAK RENEWAL 3 HE is a sophisticated medical device in the category of 'Cardiac Rhythm Management Devices'. Predominantly, it is built to diagnose, monitor, treat, and manage heart rhythm problems, popularly known as arrhythmias, which involve irregular heartbeats.
Primary Purpose and Function
The principal medical use of CONTAK RENEWAL 3 CONTAK RENEWAL 3 HE is to deliver electrical pulses or shocks to the heart to regulate abnormal heart rhythms. In particular, this device is beneficial for patients with life-threatening arrhythmias such as ventricular fibrillation and ventricular tachycardia.
This modern cardiac device is capable of performing both defibrillation and cardia
How It Works:
The CONTAK RENEWAL 3 CONTAK RENEWAL 3 HE
The CONTAK RENEWAL 3 CONTAK RENEWAL 3 HE is a sophisticated medical device belonging to the Cardiac Rhythm Management Devices category. This state-of-the-art device is primarily used to manage and rectify conditions related to abnormal heart rhythm.
Functionality
The main functionality of CONTAK RENEWAL 3 CONTAK RENEWAL 3 HE revolves around two principal treatments: cardiac resynchronization therapy (CRT) and anti-tachycardia pacing (ATP). CRT aids in improving the heart's efficiency and coordination, while ATP is employed to control rapid heartbeats.
Primarily, it functions as a pacemaker, administering electrical impulses to treat slower heart rhythms. By pacing the ventricles, the device assists in the synchronised beating of the heart chambers, improving overall cardiac function.
Moreover, this device encompasses defibrillator capabilities, capable of delivering rapid electrical pulses or shocks to the heart to rectify dangerously rapid heart rhythms, also known as tachycardia. More specifically, it uses a technique called Anti-Tachycardia Pacing to terminate slow ventricular tachycardia without the need for high-energy shocks.
Integrated Technology
The CONTAK RENEWAL 3 CONTAK RENEWAL 3 HE is designed to adapt to the patient’s changing needs. It features advanced sensors that monitor various physiological parameters, allowing it to adjust its pacing based on the patient's activity level.
In summary, the CONTAK RENEWAL 3 CONTAK RENEWAL 3 HE is an integral tool for modern cardiovascular therapy, contributing significantly to advancements in Cardiac Rhythm Management. Through a blend of contemporary technology and sophisticated design, it offers a powerful solution to manage and rectify issues related to abnormal heart rhythm.
Manufacturer:
Boston Scientific Corp.
Status: In Stock
Are you the owner or manufacturer of this device? Need to update anything on this page or get in touch with us? Click here.